Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Prestige Consumer Healthcare (PBH)
NYSE:PBH
RESEARCH TOOLSreports
Holding PBH?
Track your performance easily
Earnings Data
Report Date
Feb 06, 2025TBA Not Confirmed
Period Ending
2025 (Q3)Consensus EPS Forecast
1.16Last Year’s EPS
1.06Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 01, 2018
|% Change Since: 2.20%
|Next Earnings Date:Aug 02, 2018
Earnings Call Sentiment|Neutral
The call presented a mixed outlook, with strong cash flow, EPS growth, and international segment performance offset by supply chain issues affecting Clear Eyes and resulting revenue declines. Management expressed confidence in overcoming these challenges and highlighted strategic initiatives to improve long-term performance.Company Guidance
During the Q2 2025 earnings call, Prestige Consumer Healthcare provided detailed financial guidance for the fiscal year. The company anticipates full-year revenues between $1.125 billion and $1.140 billion, reflecting approximately 1% organic growth compared to fiscal 2024, despite challenges like the Clear Eyes supply chain constraints. They expect Q3 revenue to rise to about $286 million, indicating a return to year-over-year growth. The adjusted EPS forecast remains in the range of $4.40 to $4.46, with expectations leaning towards the higher end due to effective debt reduction. Free cash flow is projected to be $240 million or more, supporting strategic capital deployment, including debt reduction and potential share repurchases. The company reported Q2 sales of $284 million, a slight decline due to specific supply chain issues. Nonetheless, they achieved a strong free cash flow of $68 million, reduced net debt by $40 million, and anticipate maintaining a gross margin around 56% for the full fiscal year.Strong Free Cash Flow
Free cash flow of $68 million in Q2 grew double digits versus the prior year, enabling capital deployment to enhance shareholder value.
EPS Growth
EPS of $1.09, up slightly from the prior year, benefiting from capital allocation strategy and improvements in interest expense and share count.
Debt Reduction and Leverage
Reduced debt by $40 million, leading to a leverage decline to 2.7x while still repurchasing shares opportunistically.
International Segment Growth
International segment revenues increased by 4.8% for the first six months, driven by strong performance from the Hydralyte brand and growth in Latin America.
Successful Marketing and Innovation in Canada
Canadian portfolio, including brands like Gaviscon, grew at a sales CAGR of approximately 4% since fiscal '20.
---
PBH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
PBH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 07, 2024 | $77.64 | $80.09 | +3.16% |
| Aug 08, 2024 | $67.89 | $66.84 | -1.55% |
| May 14, 2024 | $71.47 | $66.46 | -7.01% |
| Feb 08, 2024 | $62.91 | $68.80 | +9.36% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Prestige Consumer Healthcare (PBH) report earnings?
Prestige Consumer Healthcare (PBH) is schdueled to report earning on Feb 06, 2025, TBA Not Confirmed.
What is Prestige Consumer Healthcare (PBH) earnings time?
Prestige Consumer Healthcare (PBH) earnings time is at Feb 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PBH EPS forecast?
PBH EPS forecast for the fiscal quarter 2025 (Q3) is 1.16.
---